Moreover, given that the amyloid model of 5XFAD used in this study lacks tau pathology, further study will be needed to determine whether TrkB reduction may lead to the acceleration of neurofibrillary tangle formation in relevant tau transgenic animal models. The gene discussed is NTRK2; the disease is amyloidosis.